Medtronic updates on Symplicity high blood pressure device
Executives at Medtronic issue an update on the medical device company's Symplicity renal denervation device for treating high blood pressure.
Medtronic  (NYSE:MDT ) executives yesterday updated analysts on its device for treating high blood pressure, a renal denervation system called Symplicity, laying out the timetable for its hypertension program.
In renal denervation, a catheter is inserted in to the renal arteries to ablate the nerves lining those vessels, which play a role in regulating blood pressure.
It's a hot market in medtech these days , as Fridley, Minn.-based Medtronic vies with Boston Scientific  (NYSE:BSX ) and cross-town rival St. Jude Medical  (NYSE:STJ ) and smaller players.